SCHEMBL4435767

SCHEMBL4435767

Fc1cccc(-c2nc3c(Cl)cccc3cc2CCNc2ncnc3[nH]cnc23)c1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAP4K4 O95819 6/20 0.40
PIK3CD O00329 10/20 0.38
LMNA P02545 3/20 0.38
HTT P42858 3/20 0.38
SMN1; SMN2 Q16637 2/20 0.38
MAPK1 P28482 1/20 0.38
AURKA O14965 1/20 0.36
DAPK3 O43293 1/20 0.36
JAK2 O60674 1/20 0.36
PRKD3 O94806 1/20 0.36
PAK4 O96013 1/20 0.36
ABL1 P00519 1/20 0.36
LCK P06239 1/20 0.36
CSF1R P07333 1/20 0.36
RET P07949 1/20 0.36
PDGFRB P09619 1/20 0.36
FGFR1 P11362 1/20 0.36
PRKACA P17612 1/20 0.36
FLT1 P17948 1/20 0.36
LTK P29376 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4436316 0.95 MAP4K4 (0.39) MAP4K4PIK3CDLMNAHTTSMN1; SMN2
SCHEMBL1598841 0.91 MAP4K4 (0.41) MAP4K4PIK3CDLMNAHTTAURKA
SCHEMBL4433351 0.91 MAP4K4 (0.41) MAP4K4PIK3CDLMNAHTTSMN1; SMN2
SCHEMBL4435660 0.88 PIK3CD (0.37) MAP4K4PIK3CDLMNAHTTSMN1; SMN2
SCHEMBL4437114 0.88 MAP4K4 (0.41) MAP4K4PIK3CDLMNAHTTSMN1; SMN2
SCHEMBL4443103 0.85 LMNA (0.40) PIK3CDLMNAHTTSMN1; SMN2MAPK1
SCHEMBL4431751 0.85 MAP4K4 (0.41) MAP4K4PIK3CDAURKADAPK3JAK2
SCHEMBL4429984 0.85 PIK3CD (0.37) PIK3CDLMNAHTTSMN1; SMN2MAPK1
SCHEMBL4180586 0.84 PIK3CD (0.40) MAP4K4PIK3CDLMNAHTTAURKA
SCHEMBL16799113 0.84 LMNA (0.39) MAP4K4PIK3CDLMNAHTTSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2137186-A1 HETEROCYCLIC COMPOUNDS AND THEIR USES Amgen Inc. (US) 2009-12-30 EP disclosed
WO-2008118468-A1 HETEROCYCLIC COMPOUNDS AND THEIR USES AMGEN INC. (US) 2008-10-02 WO disclosed